NASDAQ:MOTS Motus GI (MOTS) Stock Price, News & Analysis → They say it’s ‘unstoppable’ – How I made 43,509% (From Investing Daily) (Ad) Free MOTS Stock Alerts $0.08 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.08▼$0.1050-Day Range$0.07▼$1.1052-Week Range$0.05▼$23.40Volume23,154 shsAverage Volume304,170 shsMarket Capitalization$407,430.00P/E RatioN/ADividend YieldN/APrice Target$28.88 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Motus GI alerts: Email Address Motus GI MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside35,548.1% Upside$28.88 Price TargetShort InterestHealthy0.98% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.39 out of 5 stars 3.5 Analyst's Opinion Consensus RatingMotus GI has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageMotus GI has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.98% of the float of Motus GI has been sold short.Short Interest Ratio / Days to CoverMotus GI has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Motus GI has recently increased by 117.67%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldMotus GI does not currently pay a dividend.Dividend GrowthMotus GI does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MOTS. Previous Next 1.1 News and Social Media Coverage News SentimentMotus GI has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.32 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Motus GI this week, compared to 1 article on an average week.Search Interest10 people have searched for MOTS on MarketBeat in the last 30 days. This is an increase of 233% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Motus GI to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Motus GI insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.57% of the stock of Motus GI is held by insiders.Percentage Held by InstitutionsOnly 20.06% of the stock of Motus GI is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Motus GI is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Motus GI is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMotus GI has a P/B Ratio of 0.05. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Investing DailyThey say it’s ‘unstoppable’ – How I made 43,509% Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. About Motus GI Stock (NASDAQ:MOTS)Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.Read More MOTS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MOTS Stock News HeadlinesApril 16, 2024 | morningstar.comMotus GI Holdings IncApril 12, 2024 | msn.comWhy Is Motus GI (MOTS) Stock Down 37% Today?April 27, 2024 | Investing Daily (Ad)They say it’s ‘unstoppable’ – How I made 43,509% Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.April 12, 2024 | investorplace.comWhy Is Motus GI (MOTS) Stock Down 37% Today?March 23, 2024 | msn.comMotus GI Holdings files to sell 4.4M common shares for holdersMarch 19, 2024 | finanznachrichten.deMotus GI Holdings, Inc.: Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateMarch 18, 2024 | investorplace.comMOTS Stock Earnings: Motus GI Hldgs Misses EPS, Misses Revenue for Q4 2023March 18, 2024 | fr.investing.comLe BPA de Motus GI Holdings a dépassé les attentes de 1,30$, le CA en dessous des prévisionsApril 27, 2024 | Investing Daily (Ad)They say it’s ‘unstoppable’ – How I made 43,509% Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.March 18, 2024 | globenewswire.comMotus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateFebruary 29, 2024 | finance.yahoo.comMotus GI Holdings, Inc. (MOTS)February 29, 2024 | businesswire.comEndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive OfficerFebruary 23, 2024 | investing.comMotus GI secures new patent for endoscopic proceduresFebruary 23, 2024 | wsj.comMotus GI Holdings Inc.February 22, 2024 | finance.yahoo.comMotus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross ProceedsFebruary 22, 2024 | globenewswire.comMotus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross ProceedsFebruary 21, 2024 | msn.comWhy Is Colonoscopy-Focused Motus GI Stock Trading Higher Today?February 21, 2024 | markets.businessinsider.comCrude Oil Moves Higher; Exelon Earnings Top EstimatesFebruary 21, 2024 | fr.investing.comMotus GI obtient un nouveau brevet pour les procédures endoscopiquesFebruary 21, 2024 | finance.yahoo.comMotus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI TractFebruary 21, 2024 | globenewswire.comMotus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI TractFebruary 16, 2024 | finance.yahoo.comMotus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of StockholdersFebruary 16, 2024 | globenewswire.comMotus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of StockholdersFebruary 14, 2024 | investing.comMotus GI Holdings Inc (MOTS)February 8, 2024 | morningstar.comMotus GI Holdings Inc MOTSJanuary 30, 2024 | finance.yahoo.comMotus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with a History of Poor Bowel PreparationJanuary 7, 2024 | finance.yahoo.comThere Are Reasons To Feel Uneasy About Motus Holdings' (JSE:MTH) Returns On CapitalSee More Headlines Receive MOTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Motus GI and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/18/2024Today4/27/2024Next Earnings (Estimated)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:MOTS CUSIPN/A CIK1686850 Webwww.motusgi.com Phone(954) 541-8000Fax954-541-8265Employees15Year FoundedN/APrice Target and Rating Average Stock Price Target$28.88 High Stock Price Target$37.50 Low Stock Price Target$20.25 Potential Upside/Downside+35,548.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($28.55) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-12,870,000.00 Net Margins-4,033.54% Pretax Margin-4,033.54% Return on EquityN/A Return on Assets-110.70% Debt Debt-to-Equity Ratio0.46 Current Ratio1.76 Quick Ratio1.69 Sales & Book Value Annual Sales$320,000.00 Price / Sales1.27 Cash FlowN/A Price / Cash FlowN/A Book Value$1.74 per share Price / Book0.05Miscellaneous Outstanding Shares5,030,000Free Float4,952,000Market Cap$407,430.00 OptionableNot Optionable Beta1.30 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Mark Pomeranz (Age 62)Non-Independent Director & CEO Comp: $877.1kMs. Ravit Ram (Age 49)CFO & VP of Global Operations Comp: $371.58kMr. Elad Amor (Age 40)Chief Accounting Officer Comp: $349.87kKey CompetitorsSintx TechnologiesNASDAQ:SINTAptevo TherapeuticsNASDAQ:APVOAmpio PharmaceuticalsNYSE:AMPEObsEvaNASDAQ:OBSVBetter TherapeuticsNASDAQ:BTTXView All CompetitorsInstitutional OwnershipArmistice Capital LLCSold 448,000 shares on 2/13/2024Ownership: 17.246%View All Institutional Transactions MOTS Stock Analysis - Frequently Asked Questions Should I buy or sell Motus GI stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MOTS shares. View MOTS analyst ratings or view top-rated stocks. What is Motus GI's stock price target for 2024? 1 brokerages have issued 1 year price objectives for Motus GI's shares. Their MOTS share price targets range from $20.25 to $37.50. On average, they anticipate the company's stock price to reach $28.88 in the next year. This suggests a possible upside of 35,548.1% from the stock's current price. View analysts price targets for MOTS or view top-rated stocks among Wall Street analysts. How have MOTS shares performed in 2024? Motus GI's stock was trading at $1.2750 on January 1st, 2024. Since then, MOTS shares have decreased by 93.6% and is now trading at $0.0810. View the best growth stocks for 2024 here. Are investors shorting Motus GI? Motus GI saw a increase in short interest in April. As of April 15th, there was short interest totaling 50,500 shares, an increase of 117.7% from the March 31st total of 23,200 shares. Based on an average daily trading volume, of 1,630,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 1.0% of the shares of the stock are sold short. View Motus GI's Short Interest. When is Motus GI's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our MOTS earnings forecast. How were Motus GI's earnings last quarter? Motus GI Holdings, Inc. (NASDAQ:MOTS) released its earnings results on Monday, March, 18th. The company reported ($4.13) earnings per share for the quarter. The business earned $0.06 million during the quarter. When did Motus GI's stock split? Shares of Motus GI reverse split on Thursday, November 2nd 2023. The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. What other stocks do shareholders of Motus GI own? Based on aggregate information from My MarketBeat watchlists, some companies that other Motus GI investors own include Matinas BioPharma (MTNB), Allena Pharmaceuticals (ALNA), VYNE Therapeutics (VYNE), Rigel Pharmaceuticals (RIGL), TherapeuticsMD (TXMD), Sorrento Therapeutics (SRNE), Pfizer (PFE), Gilead Sciences (GILD) and Marinus Pharmaceuticals (MRNS). When did Motus GI IPO? Motus GI (MOTS) raised $21 million in an initial public offering (IPO) on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager. How do I buy shares of Motus GI? Shares of MOTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MOTS) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe World's First "$20 Trillion Drug?"Behind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Motus GI Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
